Dr. Charles Bonanno is a pharmacist who is specialized in Pharmacotherapy in Pembroke Pines, Florida. Patients can reach him at 10016 Pines Blvd, Pembroke Pines or contact him on 954-435-7200. Active license number of Dr. Charles Bonanno is PS20670 for Pharmacotherapy in Florida. Dr. Charles Bonanno is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Charles Bonanno speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Charles Bonanno are as mentioned below.
NPI Number:
1861498842
NPI Enumeration Date:
23 Jun, 2005
NPI Last Update On:
19 Jun, 2023
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Charles Bonanno are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
PS20670
Florida
Primary
Geriatric
PU 5487
Florida
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
10016 Pines Blvd, Pembroke Pines, Florida
Zip:
33024-6137
Phone Number:
954-435-7200
Fax Number:
954-424-9782
Patients can reach Dr. Charles Bonanno at 10016 Pines Blvd, Pembroke Pines, Florida or can call on phone at 954-435-7200.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.